Literature DB >> 17555944

The PIP5K2A gene and schizophrenia in the Chinese population--a case-control study.

ZangDong He1, ZhiQiang Li, YongYong Shi, Wei Tang, Ke Huang, Gang Ma, Jian Zhou, JunWei Meng, HuaFang Li, GuoYing Feng, Lin He.   

Abstract

Results from a number of molecular and pharmacological studies suggest that the phosphatidylinositol-4-phosphate 5-kinase IIalpha (PIP5K2A) gene may be involved in the development of schizophrenia. A recent family-based transmission disequilibrium test in the German and Israeli populations found that four single nucleotide polymorphisms, rs1417374, rs10828317, rs746203 and rs8341 in this gene or nearby intergenic regions are significantly associated with schizophrenia. The objective of our study was to investigate whether these four SNPs are also associated with schizophrenia in the Chinese population. Our study found that SNP rs8341 (p=0.0045, Odds Ratio=1.415, 95%CI=1.113-1.799 for the minor allele) and a haplotype (p=0.0039, Odds Ratio=1.440, 95%CI=1.123-1.845) are significantly associated with schizophrenia. Our results confirm that the PIP5K2A gene merits further study as a susceptible gene for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555944     DOI: 10.1016/j.schres.2007.04.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

Review 1.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

2.  PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3.

Authors:  Olga Fedorenko; Cai Tang; Mentor Sopjani; Michael Föller; Eva-Maria Gehring; Nathalie Strutz-Seebohm; Oana N Ureche; Svetlana Ivanova; Arkadij Semke; Florian Lang; Guiscard Seebohm; Undine E Lang
Journal:  Psychopharmacology (Berl)       Date:  2009-07-31       Impact factor: 4.530

3.  A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.

Authors:  Olga Fedorenko; Nathalie Strutz-Seebohm; Ulrike Henrion; Oana N Ureche; Florian Lang; Guiscard Seebohm; Undine E Lang
Journal:  Psychopharmacology (Berl)       Date:  2008-06-11       Impact factor: 4.530

4.  Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).

Authors:  D L Thiselton; B S Maher; B T Webb; T B Bigdeli; F A O'Neill; D Walsh; K S Kendler; B P Riley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

Review 5.  Defective phosphoinositide metabolism in autism.

Authors:  Christina Gross
Journal:  J Neurosci Res       Date:  2016-07-04       Impact factor: 4.164

6.  Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.

Authors:  Evan K Noch; Isaiah Yim; Teresa A Milner; Lewis C Cantley
Journal:  J Comp Neurol       Date:  2020-06-26       Impact factor: 3.215

7.  Kv7 Channels and Excitability Disorders.

Authors:  Frederick Jones; Nikita Gamper; Haixia Gao
Journal:  Handb Exp Pharmacol       Date:  2021

8.  Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.

Authors:  Olga Yu Fedorenko; Anton J M Loonen; Florian Lang; Valentina A Toshchakova; Evgenia G Boyarko; Arkadiy V Semke; Nikolay A Bokhan; Nikolay V Govorin; Lyubomir I Aftanas; Svetlana A Ivanova
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-28       Impact factor: 5.176

9.  Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.

Authors:  Harpreet Kaur; Ajay Jajodia; Sandeep Grover; Ruchi Baghel; Meenal Gupta; Sanjeev Jain; Ritushree Kukreti
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

10.  Genetic polymorphisms of PIP5K2A and course of schizophrenia.

Authors:  Evgeniya G Poltavskaya; Olga Yu Fedorenko; Natalya M Vyalova; Elena G Kornetova; Nikolay A Bokhan; Anton J M Loonen; Svetlana A Ivanova
Journal:  BMC Med Genet       Date:  2020-10-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.